Skip to main content
OpenTrials

Clinical trial condition

Spinocerebellar Degenerations

Explore clinical trials studying Spinocerebellar Degenerations. Study availability and eligibility vary by location and protocol.

168 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Spinocerebellar Degenerations trial results

Recruiting

A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia

NCT06953583

Conditions
Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +11 more
Locations
  • UCLA Neurology Outpatient Clinic at Westwood Los Angeles, California, United States
  • Norman Fixel Institute for Neurological Diseases UF Health Gainesville, Florida, United States
  • USF Health Morsani College of Medicine Department of Neurology Tampa, Florida, United States
  • Children's Hospital of Philadelphia - Buerger Center for Advanced Pediatric Care - PIN Philadelphia, Pennsylvania, United States
View all 34 locations
View Trial Details
Recruiting

A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors

NCT06623890

Conditions
Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +11 more
Locations
  • UCLA Neurology Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
  • University of Florida Gainesville, Florida, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View all 14 locations
View Trial Details
Recruiting

Patient-reported, Health Economic and Psychosocial Outcomes in Friedreich Ataxia

NCT05943002

Conditions
Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +11 more
Locations
  • Klinik für Neurologie, Medizinische Universität Innsbruck Innsbruck, Austria
  • Paris Brain Institute Paris, France
  • Department of Neurology, RWTH Aachen University Aachen, Germany
  • German Center for Neuro-degenerative Diseases (DZNE) Bonn, Germany
View Trial Details

Related conditions